With a market capitalization (market cap) of $2.01B — a measure of how much the company is worth — Progyny, Inc. is the 2107th most valuable company in Healthcare as of August 18, 2026. Shares trade at $25.71, up +1.50% on the day.
of 2,587
price ÷ annual EPS
FY 2025
FY 2025
FY 2025
FY 2025
FY 2025
FY 2025
FY 2025
FY 2025
FY 2025
FY 2025
FY 2025
FY 2025
FY 2025
FY 2025
FY 2025
FY 2025
FY 2025
Progyny, Inc. functions as a benefits management corporation, dedicated to providing specialized solutions for fertility and broader family-building initiatives to employers throughout the United States. Its core fertility offering is characterized by a distinctive benefits plan architecture, paired with personalized, white-glove member support services and access to a meticulously chosen network of top-tier fertility specialists. Additionally, the company presents Progyny Rx, an all-encompassing pharmacy benefits solution that ensures its members can readily acquire the essential medications for their treatments. Moreover, Progyny facilitates employer-sponsored reimbursement programs to support surrogacy and adoption journeys. The company, which was established in 2008 and has its main offices in New York City, previously operated as Auxogyn, Inc. before adopting the Progyny, Inc. moniker in 2015.
Visit websiteAs of August 18, 2026, Progyny, Inc. (PGNY) is worth $2.01B — this is its market capitalization, the total value of all its outstanding shares.
Progyny, Inc.’s market cap is $2.01B, which ranks it #2107 among the most valuable companies in the Healthcare sector tracked on MarketCapLens.
Progyny, Inc. (PGNY) shares trade at $25.71, up 1.50% on the day, as of August 18, 2026.
Progyny, Inc. trades at a price-to-earnings (P/E) ratio of 37.8, based on its latest share price and annual earnings per share.
Fundamentals are annual. Figures labeled with their fiscal year.
FY 2025